Q3 FY25/26 SOL abdc pharm#100067389 and 2 more items

AmerisourceBergen Drug Corporation has been awarded a contract by the California Department of Corrections and Rehabilitation for pharmaceutical and over-the-counter (OTC) medical supplies. The contract, valued at $2,508,854.00, is for a single fiscal quarter (Q3 FY25/26) and encompasses three distinct line items: a primary pharmaceutical order (ABDC PHARM) with 2,343,354 units, an OTC medical supply order (ABDC OTC) with 30,000 units, and a 340B program pharmaceutical order with 135,500 units.

The contract is structured with a uniform unit price of $1.00 across all line items, suggesting a potential bulk or consolidated pricing mechanism. Awarded on January 1, 2026, with the same date noted for contract completion, this appears to be a targeted, short-term supply agreement focused on meeting the medical supply needs of California's corrections system. The contract type is classified as "NON-IT Goods," indicating a focus on physical medical products rather than technological services or solutions.